Alembic Pharmaceuticals Ltd - Announcement under Regulation 30 (LODR)-Press Release / Media Release
15 Nov 2025
Alembic Pharmaceuticals Limited announces USFDA Final Approval for Diltiazem Hydrochloride Tablets USP 30 mg, 60 mg, 90 mg and 120 mg
Source:
BSE India